The week ahead holds significant developments for investors with high-stakes earnings reports and economic updates on the October jobs report, the Q3 GDP report, and major companies’ quarterly earnings. This article Amazon, Microsoft, Apple, and more are set to report earnings this week, What they reveal might change the game! ♟️ appeared first on Guerilla…
Scholar Rock experienced a dramatic surge in its stock price on October 7, 2024, after announcing positive results from its Phase 3 SAPPHIRE clinical trial for apitegromab, a promising treatment for spinal muscular atrophy (SMA). This article This drug just changed the game for spinal muscular atrophy—315% stock surge?! The breakthrough EVERYONE is talking about!…
Michael Yee Downgrades Moderna to “Hold” Michael Yee, in his recent interview with Yahoo Finance, explained his decision… This article Michael Yee’s Moderna Downgrade appeared first on Guerilla Stock Trading. Source link
Intelligent Bio Solutions stock experienced a significant decline on September 18, 2024, despite the company’s impressive revenue growth.… This article Why Did Intelligent Bio Solutions Stock Tumble Despite a Strong Earnings Report? 🧐 appeared first on Guerilla Stock Trading. Source link
NuCana stock experienced a dramatic increase on September 16, 2024, following the release of positive clinical trial results… This article NuCana stock explodes 160% after breakthrough melanoma treatment results! 🚀 appeared first on Guerilla Stock Trading. Source link
In a recent move that escalates the ongoing China and US trade war, the U.S. House of Representatives approved the BIOSECURE Act, a legislative measure aimed at restricting U.S. companies from collaborating with several China-based biotechnology firms. This article China and US Trade War Update: The Biosecurity Act just went next level—what it means for…
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, will adversely affect certain features and functions. The technical storage or access is strictly…
Hoth Therapeutics has recently made headlines with a substantial surge in its stock price, following promising data from the treatment of the first patient using its lead drug candidate, HT-001. This positive development has sparked renewed interest in the Hoth Therapeutics stock. This article Hoth Therapeutics breakthrough! 🧬✨ Why one patient sent Hoth Therapeutics stock…
Virax Biolabs experienced a notable increase in stock value on August 28, 2024, following the announcement of a… This article Virax Biolabs is making waves in the diagnostic market! 🚀 New RT-PCR kits for Mpox are shaking up Europe and the Middle East appeared first on Guerilla Stock Trading. Source link
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, will adversely affect certain features and functions. The technical storage or access is strictly…